NCT03846817

Brief Summary

This prospective study with a two-group comparison design investigates the effectiveness of 12-weeks of semi-structured and supervised physiotherapist-led treatment on self-reported hip and groin function in patients with femoroacetabular impingement syndrome with and without intra-articular hip pain. Determination of intra-articular hip pain is based on pain relief following an ultrasound-guided intra-articular anesthetic hip injection performed prior to commencing treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 20, 2019

Completed
20 days until next milestone

Study Start

First participant enrolled

March 12, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2021

Completed
Last Updated

July 28, 2020

Status Verified

July 1, 2020

Enrollment Period

2 years

First QC Date

February 18, 2019

Last Update Submit

July 27, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in HAGOS Sport subscale

    The primary outcome measure is the between-group (intra-articular pain vs. no intra-articular pain) difference in change in self-reported hip and groin function, measured with the Copenhagen Hip and Groin Outcome Score (HAGOS) Sport subscale from baseline to follow-up in subjects diagnosed with FAIS. The HAGOS Sport subcale is scored on a scale from 0 (extreme hip and groin problems) to 100 (no hip and groin problems).

    12 weeks

Secondary Outcomes (8)

  • Change in HAGOS subscales

    12 weeks

  • Change in hip peak torque

    12 weeks

  • Change in hip rate of torque development

    12 weeks

  • Change in single leg hop performance

    12 weeks

  • Change in isometric adduction squeeze torque

    12 weeks

  • +3 more secondary outcomes

Study Arms (2)

FAIS with intra-articular hip pain

EXPERIMENTAL

12-week of semi-standardized, progressive physiotherapist-led treatment supervised by a physiotherapist blinded to clinical and objective findings. The treatment program will consist of one weekly exercise training session at Hvidovre Hospital supervised by a physiotherapist and twice-weekly unsupervised exercise training sessions performed at home for a consecutive period of 12-weeks (12 supervised sessions; 24 unsupervised sessions). In conjunction with the physiotherapist-led treatment, participants will be advised to modify potential aggravating physical activitie, and gradually increase their level of activity during the treatment period.

Other: Physiotherapist-led treatment

FAIS without intra-articular hip pain

EXPERIMENTAL

12-week of semi-standardized, progressive physiotherapist-led treatment supervised by a physiotherapist blinded to clinical and objective findings. The treatment program will consist of one weekly exercise training session at Hvidovre Hospital supervised by a physiotherapist and twice-weekly unsupervised exercise training sessions performed at home for a consecutive period of 12-weeks (12 supervised sessions; 24 unsupervised sessions). In conjunction with the physiotherapist-led treatment, participants will be advised to modify potential aggravating physical activitie, and gradually increase their level of activity during the treatment period.

Other: Physiotherapist-led treatment

Interventions

12-week of semi-standardized, progressive physiotherapist-led treatment aiming to increase hip muscle strength and load capacity.

Also known as: Exercise-based treatment
FAIS with intra-articular hip painFAIS without intra-articular hip pain

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Activity-related longstanding hip and/or groin pain for \>3 months
  • Known anterior and/or medial groin pain during the FADIR test with a pain severity of ≥2/10 on NRS.
  • Radiological findings on plain radiographs of cam morphology defined as alpha angle \>55° on a lateral view.

You may not qualify if:

  • Inguinal-related groin pain diagnosed according to Doha Agreement.
  • Pubic-related groin pain diagnosed according to Doha Agreement.
  • Evidence of pre-existing hip osteoarthritis, defined as a joint space width \<3 mm at the lateral sourcil on anterior-posterior pelvic radiograph.
  • Previous hip pathology such as Perthes' disease, slipped upper femoral epiphysis, hip dysplasia defined as a Lateral Center Edge Angle \<25°, or avascular necrosis.
  • Other causes of hip and groin pain identified by the orthopedic surgeon during the clinical examination, such as stress fracture of the femoral neck, referred pain from the facet joint, referred pain from the sacroiliac joint, or other competing diagnosis (rheumatoid arthritis, cancer etc.)
  • Previous hip injury such as acetabular fracture, hip dislocation, or femoral neck fracture.
  • Previous intra- or extra-articular hip surgery.
  • Pregnant.
  • Intra-articular steroid hip injection during the preceding 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All part of the study is conducted at Department of Orthopedic Department, Hvidovre Hospital

Copenhagen, Denmark

RECRUITING

MeSH Terms

Conditions

Femoracetabular Impingement

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lasse Ishøi

    Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

    PRINCIPAL INVESTIGATOR
  • Per Hölmich

    Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

    STUDY DIRECTOR
  • Kristian Thorborg

    Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital

    STUDY DIRECTOR
  • Joanne Kemp

    La Trobe Sport and Exercise Medicine Research Centre, La Trobe University

    STUDY CHAIR
  • Michael Reiman

    Duke University Medical Center, Duke University

    STUDY CHAIR

Central Study Contacts

Lasse Ishøi, PhD student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants will be blinded to the potential value of the diagnostic findings, such as response to intra-articular hip injection. Outcome assessor will be blinded to diagnostic findings, such as response to intra-articular hip injection. Care Provider (Physiotherapist supervising the intervention) will be blinded to diagnostic findings, such as response to intra-articular hip injection.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 18, 2019

First Posted

February 20, 2019

Study Start

March 12, 2019

Primary Completion

March 12, 2021

Study Completion

March 12, 2021

Last Updated

July 28, 2020

Record last verified: 2020-07

Locations